Skip to main content
Boule Diagnostics logo

Boule Diagnostics — Investor Relations & Filings

Ticker · BOUL ISIN · SE0011231158 LEI · 213800IK1TGY858TKZ45 ST Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2025-10-13 Board/Management Inform…
Country SE Sweden
Listing ST BOUL

About Boule Diagnostics

https://boule.com/

Boule Diagnostics is a global provider of diagnostic solutions specializing in hematology. The company develops, manufactures, and markets systems and consumables for blood diagnostics, including hematology analyzers, clinical chemistry analyzers, and associated reagents, controls, and calibrators. Its products are tailored for decentralized healthcare settings in both the human and veterinary markets, such as smaller laboratories and clinics. The company aims to enhance global healthcare access by providing high-quality instruments that deliver timely and accurate blood test results.

Recent filings

Filing Released Lang Actions
Boule Diagnostics CFO lämnar för ny möjlighet
Board/Management Information Classification · 1% confidence The document is a corporate announcement regarding the resignation of the company's Chief Financial Officer (CFO). It details the departure, the transition period, and provides contact information. This falls directly under the category of announcements concerning changes in senior management.
2025-10-13 Swedish
Boule Diagnostics Announces CFO Departure for New Opportunity
Board/Management Information Classification · 1% confidence The document is a formal announcement regarding the departure of the company's Chief Financial Officer (CFO). It details the resignation, the transition period, and the CEO's comments. This falls directly under the category of announcements concerning changes in senior management.
2025-10-13 English
Director's Dealing 2025
Director's Dealing Classification · 1% confidence The document details a change in shareholding ('Sälj' - Sell) by an entity (Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension) concerning the issuer (Boule Diagnostic AB). It specifies the number of shares held before and after the transaction, the resulting percentage ownership (4.60194%), and the date of the transaction (2025-07-18). This structure is characteristic of a mandatory notification regarding significant changes in share ownership, often referred to as a 'flagging' notification in Nordic markets. This aligns directly with the definition for Major Shareholding Notification (MRQ).
2025-07-21 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding ('Köp' - Purchase) for an entity (Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension) in Boule Diagnostic AB. It explicitly states the resulting share percentage (5.00821%) and the total number of shares (1,944,844) after the transaction, referencing thresholds ('Gränsvärde för antal aktier: 5 %'). This structure is characteristic of a Major Shareholding Notification, where an investor crossing a specific ownership threshold (often 5% or 10%) must report the change to the relevant financial authority. In the provided definitions, 'Major Shareholding Notification' corresponds to code MRQ.
2025-07-18 Swedish
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for Q2 2025, which contains comprehensive financial statements, key performance indicators (KPIs), management commentary, and regional/product-based revenue breakdowns. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q2 2025
2025-07-18 Swedish
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Report Q2 2025' and contains comprehensive financial statements, key performance indicators, management commentary, and regional/product sales breakdowns for the second quarter of 2025. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q2 2025
2025-07-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.